Gutclear® Plus Suspension (Sodium Picosulfate 3.33 mg + Liquid Paraffin 1.25 ml + Milk of Magnesia 3.75 ml) is a triple-action laxative formulated to relieve constipation, characterized by infrequent bowel movements and hard, dry stools. It works by drawing water into the intestines, softening stools, and promoting easier passage. The syrup also stimulates bowel movements, aiding in smooth and complete evacuation. Gutclear® Plus Refreshing Sugar-Free suspension offers fast relief while reducing discomfort and improving overall quality of life. It provides effective relief with fast action, soft stools, and a clear gut.

Zuventus has always been at the forefront in bringing innovation and excellence in Healthcare.

As part of this commitment to the medical fraternity & patients, Zuventus introduced a novel concept-based molecule, Trelagliptin (Trelaglip), a Once-Weekly Oral DPP4i for the management of Type 2 Diabetes Mellitus (T2DM), designed to address existing challenges in glycemic control & patient compliance.

Trelaglip makes a difference to QoL with Compliance & Control, available in 3 SKUs (100 MG, 50 MG & 25 MG) 

• For the first time in India, Zuventus conducted a clinical trial comparing Trelagliptin 100 MG (once-weekly) vs. Vildagliptin 50 MG BID & got CDSCO approval.

Know More about Trelaglip

Zuventus has always been at the forefront in bringing innovation and excellence in Healthcare.

As part of this commitment to the medical fraternity & patients, Zuventus introduced a novel concept-based molecule, Trelagliptin (Trelaglip), a Once-Weekly Oral DPP4i for the management of Type 2 Diabetes Mellitus (T2DM), designed to address existing challenges in glycemic control & patient compliance.

Trelaglip makes a difference to QoL with Compliance & Control, available in 3 SKUs (100 MG, 50 MG & 25 MG) 

• For the first time in India, Zuventus conducted a clinical trial comparing Trelagliptin 100 MG (once-weekly) vs. Vildagliptin 50 MG BID & got CDSCO approval.

Know More about Trelaglip

Composition: Each Sachet contains: Not less than 30.0 billion CFU of Bifidobacteria (B. Longum DSM 24736, B. Breve DSM 24372, B. Infantis DSM 24737), Streptococcus Thermophilus (DSM 24731) Lactobacillus Acidophilus (DSM 24735), Lactobacilus Casei (DSM 24733), Lactobacillus Delbrueckii Subsp, Bulgaricus (DSM 24734), Lactobacillus Plantarum (DSM 24730). Appropriate overages added to compensate loss on storage.

Indications: For management of rotavirus diarrhoea in children.

Contra-indications: Hypersensitivity to the active substance or to any of the excipients listed in the formulation.

Warnings and precautions: Florimax Jr sachets are typically compatible with most medications. If taking antibiotics, it is recommended to take Florimax Jr at a different time to avoid potential interactions. Exercise caution when using Florimax Jr in patients with lactose intolerance or a milk allergy, and assess individual tolerance to ensure safety and effectiveness. Do not exceed the stated recommended daily dose.

Adverse effects: Mild bloating. If you encounter bloating, it is advisable to reduce your daily dosage.

Dosage of administration: 1-2 sachets a day with single or divided doses. Mix the contents of sachet in infant formula, cold milk, water, yogurt or juice, and consume immediately. Do not exceed the recommended daily dose.

(For detailed information please write to Zuventus Healthcare Limited, Plot Y2, CTS No: 358/A2, Near Nahur Railway station, Nahur (west) Mumbai 400078 or email to medico@zuventus.com)

Floresp-OX is a combination nasal spray that combines the Fluticasone Furoate (an intranasal steroid) and Oxymetazoline (a nasal decongestant) for the relief of inflammation and nasal congestion associated with allergic rhinitis. Floresp-OX provides faster onset of action and long term control of nasal inflammation and symptoms. It reduces risk of rebound congestion associated with prolonged use of Oxymetazoline. Fluticasone Furoate in Floresp-OX prevents development of tachyphylaxis caused by Oxymetazoline. Floresp-OX offers convenience of combination therapy in single nasal spray. Floresp-OX is indicated in children more than 12 years age and the recommended dose is two spray actuations (27.5 mcg of Fluticasone and 50 mcg of Oxymetazoline per spray actuation) in each nostril once daily.